NEW YORK (GenomeWeb) – Software firm Syapse said today that it raised $10 million in a Series B financing round led by Safeguard Scientifics with participation from Series A investor The Social+Capital Partnership.

Syapse said that it will use the funds to expand its sales, marketing, and client services, as well as further accelerate product development. The funds will also support the firm's efforts to provide its Precision Medicine Data platform to healthcare providers, enabling them to use genomics and clinical data in their treatment decisions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.